GleamWall
中文EN

LFST LifeStance Health Group, Inc.

Services-Health Services · Nasdaq · SEC CIK 1845257 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY22.6%
TTM net income YoY888.7%
TTM EPS YoY884.0%
Revenue 3-yr CAGR18.6%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin6.2%
Net margin4.3%
FCF margin10.7%
EBITDA margin8.8%

Returns

ROE4.8%
ROA3.3%
ROIC (approx.)5.4%
Asset turnover0.77x

Leverage & solvency

Liabilities / assets31.7%
Debt / equity0.18x
Current ratio1.44x
Interest coverage10.63x

Cash quality & payout

Operating cash flow / net income3.17x
Accruals ratio-7.2%
Payout ratio—
Capex / revenue2.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$455.86M$435.35M$403.48M$382.19M$363.81M$345.31M$332.97M$325.48M
SG&A expense$113.39M$108.14M$100.33M$94.78M$95.61M$97.38M$94.43M$93.71M
Operating income$33.08M$30.65M$22.28M$18.08M$7.41M-$2.95M$1.60M$1.06M
Interest expense$2.49M$2.63M$1.79M$2.88M$2.81M$2.90M$3.07M$9.40M
Pretax income$27.40M$27.46M$19.76M$15.20M$4.57M-$5.94M-$1.47M-$8.88M
Income tax$5.02M$3.85M$5.52M$3.54M$3.50M-$2.15M-$2.18M-$1.76M
Net income$22.39M$23.61M$14.24M$11.67M$1.08M-$3.79M$709,000-$7.11M
EBITDA$45.13M$41.96M$32.65M$28.43M$17.75M$7.69M$11.89M$11.18M
EPS (diluted)————————
Weighted avg. shares (diluted)391.22M387.30M395.08M—388.89M386.73M390.67M—
Balance sheet
Cash & equivalents$218.82M$225.94M$194.80M$248.64M$203.90M$188.93M$134.34M$154.57M
Receivables$120.94M$110.96M$122.92M$95.71M$121.07M$129.48M$140.37M$131.80M
Current assets$376.78M$377.97M$355.91M$416.20M$360.38M$358.85M$304.63M$312.51M
PP&E, net$166.43M$164.70M$161.47M$161.58M$162.67M$160.62M$163.72M$166.04M
Goodwill$1.31B$1.30B$1.30B$1.29B$1.29B$1.29B$1.29B$1.29B
Intangibles$170.04M$172.81M$175.14M$177.66M$180.75M$183.97M$187.33M$190.80M
Total assets$2.19B$2.18B$2.15B$2.20B$2.15B$2.15B$2.10B$2.12B
Current liabilities$261.13M$274.75M$239.73M$251.96M$228.56M$242.28M$207.38M$228.89M
Short-term debt$14.50M$14.50M$18.12M$14.50M$12.69M$10.88M$9.06M$7.25M
Long-term debt$255.52M$258.99M$262.46M$265.93M$269.39M$272.86M$276.32M$279.79M
Total debt$270.02M$273.49M$280.58M$280.43M$282.08M$283.73M$285.38M$287.04M
Total liabilities$693.89M$704.35M$668.47M$682.92M$656.23M$672.88M$647.57M$672.01M
Shareholders' equity$1.49B$1.48B$1.48B$1.52B$1.49B$1.47B$1.46B$1.45B
Net debt$51.21M$47.55M$85.79M$31.79M$78.18M$94.80M$151.05M$132.47M
Shares outstanding380.19M382.02M387.81M388.32M389.00M389.08M388.83M382.74M
Cash flow statement
Operating cash flow$37.02M$99.91M$33.11M$57.56M$27.29M$64.40M-$3.09M$62.32M
Capital expenditure$14.65M$11.99M$10.77M$10.91M$10.29M$7.75M$7.17M$6.30M
Free cash flow$22.36M$87.92M$22.34M$46.65M$17.00M$56.64M-$10.26M$56.02M
Investing cash flow-$15.21M-$17.89M-$13.91M-$10.91M-$10.29M-$7.75M-$7.17M-$6.30M
Financing cash flow-$28.93M-$50.88M-$73.04M-$1.91M-$2.02M-$2.05M-$9.97M-$4.06M
Depreciation & amortization$12.05M$11.31M$10.37M$10.35M$10.34M$10.64M$10.29M$10.12M
Stock-based compensation$18.17M$19.75M$15.20M$16.70M$18.30M$21.12M$18.58M$16.15M
Share buybacks$24.80M$48.52M$49.11M—$0$0$0—

Free plan shows the latest 8 periods; Pro shows all 26 🔒

· This company does not report gross profit in XBRL.

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.